Recently added
This page was added on 04 June 2018.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Sponsor
Pfizer Australia
Administration route
Intramuscular injection
Vaccine group
Meningococcal B vaccines
Description:
Registered for use in children aged ≥10 years and in adults.
MenB-fHBP — recombinant lipidated factor H binding protein meningococcal serogroup B vaccine
Each 0.5 mL monodose pre-filled syringe contains:
- 60 µg Neisseria meningitidis serogroup B factor H binding protein subfamily A
- 60 µg Neisseria meningitidis serogroup B factor H binding protein subfamily B
May contain traces of:
- histidine
- aluminium phosphate
- polysorbate 80
For Product Information and Consumer Medicine Information about Trumenba visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.
Related diseases
Page history
Last updated
Last reviewed